1. Fox, J. G., Wang, T. C. (2001). Helicobacter pylori --
Not a Good Bug after All. N Engl J Med 345: 829-832
2. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter
pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
3. Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez
GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese
Americans in Hawaii. N Engl J Med 1991;325:1132-1136.
4. Huang J-Q, Sridhar S, Chen Y, Hunt RH. Meta-analysis of
the relationship between Helicobacter pylori seropositivity and gastric cancer.
Gastroenterology 1999;114:1169-1179.
5. Naomi "2.9" and "0", M.D., Shiro Okamoto,
M.D., Soichiro Yamamoto, M.D., Nobutoshi Matsumura, M.D., Shuji Yamaguchi,
M.D., Michio Yamakido, M.D., Kiyomi Taniyama, M.D., Naomi Sasaki, M.D., and
Ronald J. Schlemper, M.D.Helicobacter pylori Infection and the Development
of Gastric Cancer. N Engl J Med 2001;345:784-789.
6. Shafiuddin M, Caminker M, Batra S. Hereditary linitis plastica
of the stomach. Am J Gastroenterol 1995;90:2062-2063
7. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline
mutations in familial gastric cancer. Nature 1998;392:402-405.
8. David G. Huntsman, M.D., Fatima Carneiro, M.D., Ph.D.,
Frank R. Lewis, M.D., Patrick M. MacLeod, M.D., Allen Hayashi, M.D., Kristin
G. Monaghan, Ph.D., Raymond Maung, M.D., Raquel Seruca, M.D., Ph.D., Charles
E. Jackson, M.D., and Carlos Caldas, M.D. Early Gastric Cancer in Young, Asymptomatic
Carriers of Germ-Line E-Cadherin Mutations. N Engl J Med 2001; 344:1904-1909
9. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric
cancer: overview and guidelines for management. J Med Genet 1999;36:873-880.
10. Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang
HP, Lin JT. Epstein-Barr virus-associated gastric carcinomas: relation to
H. pylori infection and genetic alterations. Gastroenterology. 2000 Jun;118(6):1031-8.
11. Clinicopathologic characteristics of Epstein-Barr virus-incorporated
gastric cancers in Korea. Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. Pathol
Res Pract. 2001;197 :395-400
12. Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC, Wang
HP, Lin JT. Epstein-Barr virus-associated gastric carcinomas: relation to
H. pylori infection and genetic alterations. Gastroenterology. 2000 Jun;118(6):1031-8.
13. Loss of p16/CDKN2A tumor suppressor protein in gastric
adenocarcinoma is associated with Epstein-Barr virus and anatomic location
in the body of the stomach. Schneider BG, Gulley ML, Eagan P, Bravo JC, Mera
R, Geradts J. Hum Pathol. 2000;31(1):45-50.
14. Gulley ML Molecular diagnosis of Epstein-Barr virus-related
diseases. J Mol Diagn. 2001 Feb;3(1):1-10.
15. Circulating Epstein-Barr virus DNA in the serum of patients
with gastric carcinoma.Lo YM, Chan WY, Ng EK, Chan LY, Lai PB, Tam JS, Chung
SC. Clin Cancer Res. 2001 Jul;7(7):1856-9.
16. Epstein-Barr virus involvement is mainly restricted to
lymphoepithelial type of gastric carcinoma among various epithelial neoplasms.
Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, Aridome K, Otsuji
T, Itoh T, Tokunaga M, Eizuru Y, Aikou T. J Med Virol. 2001 Aug;64(4):513-8.
17. Possible association of active gastritis, featuring accelerated
cell turnover and p53 overexpression, with cancer development at anastomoses
after gastrojejunostomy. Comparison with gastroduodenostomy. Tanigawa H, Uesugi
H, Mitomi H, Saigenji K, Okayasu I. Am J Clin Pathol. 2000;114:354-63.
18. Microsatellite instability and Epstein-Barr virus infection
in gastric remnant cancers. Chang MS, Lee JH, Kim JP, Kim HS, Lee HS, Kim
CW, Kim YI, Kim WH. Pathol Int. 2000 Jun;50(6):486-92.
19. Isolation of the Epstein-Barr virus in scirrhous gastric
cancer by efficiency-monitored representational difference analysis. Mita
H, Itoh F, Toyota M, Hinoda Y, Imai S, Imai K. Tumour Biol. 2000;21:249-57.
